The combination treatment significantly enhanced apoptosis and reduced tumor burden compared to monotherapy, suggesting that TQ may sensitize resistant cancer cells to proteasome inhibition via NF-κB pathway modulation [55]. Here, NFKB1 is linked to neoplasm.